A Study of the Effect of Bran, Psyllium and Nopal on Intestinal Water Content Using Magnetic Resonance Imaging (NOPAL)
Primary Purpose
Constipation, Diet Modification
Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Bran
Nopal
Psyllium
Sponsored by
About this trial
This is an interventional basic science trial for Constipation focused on measuring Nopal, Bran, Psyllium
Eligibility Criteria
Inclusion Criteria:
- Aged 18 or older
- Able to give informed consent
Exclusion Criteria:
- Pregnancy declared by candidate
- History declared by the candidate of pre-existing gastrointestinal disorder that may affect bowel function
- A positive diagnosis of irritable bowel syndrome based on the Rome IV criteria questionnaire
- Reported history of previous resection of the oesophagus, stomach or intestine (excluding appendix)
- Intestinal stoma
- Any medical condition making participation potentially compromising participation in the study e.g. diabetes mellitus, respiratory disease limiting ability to lie in the scanner, known allergy to one of the food products
- Contraindications for MRI scanning i.e. metallic implants, pacemakers, history of metallic foreign body in eye(s) and penetrating eye injury
- Will not agree to dietary restrictions required in 24 hours before each MRI study day
- Unable to stop drugs known to alter GI motility including mebeverine, opiates, monoamine oxidase inhibitors, phenothiazines, benzodiazepines, calcium channel antagonists for the duration of the study (Selective serotonin reuptake inhibitors and low dose tricyclic antidepressants will be recorded but will not be an exclusion criteria)
- Inability to lie flat or exceed scanner limits of weight <120kg
- Poor understanding of English language
- Participation in night shift work the week prior to the study day. Night work is defined as working between midnight and 6.00 AM
- Participation in any medical trials for the past 3 months
- Anyone who in the opinion of the investigator is unlikely to be able to comply with the protocol e.g. cognitive dysfunction, chaotic lifestyle related to substance abuse
Sites / Locations
- University of Nottingham
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Experimental
Arm Label
Nopal added to test meal
Psyllium added to test meal
Bran added to test meal
Arm Description
test meal including nopal powder
test meal including psyllium powder
test meal including bran powder
Outcomes
Primary Outcome Measures
Change from the baseline in T1 relaxation time (ms) of the chyme in the ascending colon
measured by MRI
Secondary Outcome Measures
Change from the baseline in small bowel water content (mL)
measured by MRI
Change from the baseline in colonic volume in mL
measured by MRI
Change from the baseline of breath hydrogen and methane (ppm)
measured using GastroCHeck
Full Information
NCT ID
NCT03263065
First Posted
August 21, 2017
Last Updated
April 16, 2019
Sponsor
University of Nottingham
1. Study Identification
Unique Protocol Identification Number
NCT03263065
Brief Title
A Study of the Effect of Bran, Psyllium and Nopal on Intestinal Water Content Using Magnetic Resonance Imaging
Acronym
NOPAL
Official Title
A Pilot Participant-blind Study of the Effect of Bran, Psyllium and Nopal on Intestinal Water Content Using Magnetic Resonance Imaging
Study Type
Interventional
2. Study Status
Record Verification Date
May 2018
Overall Recruitment Status
Completed
Study Start Date
April 18, 2018 (Actual)
Primary Completion Date
October 1, 2018 (Actual)
Study Completion Date
November 1, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Nottingham
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will compare 3 food products (bran, psyllium and nopal) on intestinal water content measured via MRI.
Detailed Description
BACKGROUND AND RATIONALE
The role of dietary fibre in human health is a topic of both debate and research. Interpreting evidence is complicated by changes in the definition of fibre. In the UK the Scientific Advisory Committee for Nutrition has recently proposed a definition of "all carbohydrates that are neither digested nor absorbed in the small intestine and have a degree of polymerisation of three or more monomeric units, plus lignin". They have also called for further research into the physiological effects of fibre of the gastrointestinal (GI) tract.
The Nottingham GI MRI group has been at the forefront of elucidating the effects of poorly digested carbohydrates on gastrointestinal physiology. The investigators have published techniques to measure free water in the small bowel and assessment of the physical form of chyme in the colon using MR relaxometry. This includes the demonstration that fructose ingestion on its own leads to increased free water in the small bowel compared to co-ingestion with glucose.
Bran is often confused with dietary fibre. Although it contains fibre, the term actually refers to the outer husk of seeds and grains. It has been shown to accelerate oro-caecal transit (OCT) with scintigraphy. Bran can also be shown to increase small bowel water content, possibly by mechanical stimulation, one of the most powerful stimuli for small intestinal secretion, which may be a mechanism to prevent blockage. In the past bran's high fibre content led to the hypothesis that its effect derived from holding water in the lumen but a comparison study of 17 different fibres found an inverse relationship between their water-holding properties and effect on faecal weight, with bran holding the least water but inducing the largest weight changes. Rather, weight change appeared to relate to the amount of undigested fibre present in the faeces and the associated changes in bacterial numbers, which account for most of dry stool weight.
In contrast, psyllium husk contains a fibre that binds water effectively. On this basis it has been used as a laxative for thousands of years. In fact, there is little evidence that psyllium accelerates whole gut transit time as might be expected of a laxative. Work within the investigating group has shown that psyllium increases water in both the small bowel and the faeces, leading to softer, looser stool.
Nopal is a Mexican dietary product derived from cactus. It contains a different mix of fibre, 2/3rds of which is insoluble like bran fibre and 1/3rd soluble like psyllium. It is the subject of several health claims. The investigating group has recently been awarded a grant by the Newton Fund, through the Medical Research council, to study its effects on gut function. The aim of the Newton Fund is to stimulate collaborative research with middle-income countries such as Mexico. Part of the project plan is to invite a Mexican radiologist, Dr Alfonso Gil-Valadez, to Nottingham to learn about the MRI techniques used by our group.
TRIAL OBJECTIVES AND PURPOSE
Purpose
The purpose of the study is to gather pilot data on the effect of Nopal on intestinal water content, in comparison to bran and psyllium.
Objective
The primary objective is to gather pilot data on the change from baseline in small bowel water content in healthy volunteers after a meal containing nopal, in comparison to meals containing psyllium or bran.
Secondary Objectives
Secondary objectives will be to gather pilot data on the effects of the fibre-containing meals on the physical form of colonic chyme, colonic volume and breath markers of fermentation.
Hypotheses
The test meals will lead to differences in post-prandial water in the small bowel.
The test meals will lead to differences in the post-prandial volume and physical composition of chyme in the colon.
The test meals will not lead to change in breath markers of fermentation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Constipation, Diet Modification
Keywords
Nopal, Bran, Psyllium
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
This will be a three-period, three-treatment crossover trial with blinding of data analysis
Masking
Outcomes Assessor
Masking Description
Data analysis will be blinded
Allocation
Randomized
Enrollment
12 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Nopal added to test meal
Arm Type
Experimental
Arm Description
test meal including nopal powder
Arm Title
Psyllium added to test meal
Arm Type
Experimental
Arm Description
test meal including psyllium powder
Arm Title
Bran added to test meal
Arm Type
Experimental
Arm Description
test meal including bran powder
Intervention Type
Dietary Supplement
Intervention Name(s)
Bran
Intervention Description
220g rice pudding meal with raspberry jam with added bran flakes
Intervention Type
Dietary Supplement
Intervention Name(s)
Nopal
Intervention Description
220g rice pudding meal with raspberry jam with added nopal flakes
Intervention Type
Dietary Supplement
Intervention Name(s)
Psyllium
Intervention Description
220g rice pudding meal with raspberry jam with added psyllium flakes
Primary Outcome Measure Information:
Title
Change from the baseline in T1 relaxation time (ms) of the chyme in the ascending colon
Description
measured by MRI
Time Frame
baseline, immediately post ingestion, 1, 2, 3 and 4 hours post ingestion
Secondary Outcome Measure Information:
Title
Change from the baseline in small bowel water content (mL)
Description
measured by MRI
Time Frame
baseline, immediately post ingestion, 1, 2, 3 and 4 hours post ingestion
Title
Change from the baseline in colonic volume in mL
Description
measured by MRI
Time Frame
baseline, immediately post ingestion, 1, 2, 3 and 4 hours post ingestion
Title
Change from the baseline of breath hydrogen and methane (ppm)
Description
measured using GastroCHeck
Time Frame
baseline, immediately post ingestion, 1, 2, 3 and 4 hours post ingestion
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Aged 18 or older
Able to give informed consent
Exclusion Criteria:
Pregnancy declared by candidate
History declared by the candidate of pre-existing gastrointestinal disorder that may affect bowel function
A positive diagnosis of irritable bowel syndrome based on the Rome IV criteria questionnaire
Reported history of previous resection of the oesophagus, stomach or intestine (excluding appendix)
Intestinal stoma
Any medical condition making participation potentially compromising participation in the study e.g. diabetes mellitus, respiratory disease limiting ability to lie in the scanner, known allergy to one of the food products
Contraindications for MRI scanning i.e. metallic implants, pacemakers, history of metallic foreign body in eye(s) and penetrating eye injury
Will not agree to dietary restrictions required in 24 hours before each MRI study day
Unable to stop drugs known to alter GI motility including mebeverine, opiates, monoamine oxidase inhibitors, phenothiazines, benzodiazepines, calcium channel antagonists for the duration of the study (Selective serotonin reuptake inhibitors and low dose tricyclic antidepressants will be recorded but will not be an exclusion criteria)
Inability to lie flat or exceed scanner limits of weight <120kg
Poor understanding of English language
Participation in night shift work the week prior to the study day. Night work is defined as working between midnight and 6.00 AM
Participation in any medical trials for the past 3 months
Anyone who in the opinion of the investigator is unlikely to be able to comply with the protocol e.g. cognitive dysfunction, chaotic lifestyle related to substance abuse
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robin Spiller, PhD
Organizational Affiliation
University of Nottingham
Official's Role
Study Chair
Facility Information:
Facility Name
University of Nottingham
City
Nottingham
State/Province
Nottinghamshire
ZIP/Postal Code
NG7 2UH
Country
United Kingdom
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
32619212
Citation
Gunn D, Murthy R, Major G, Wilkinson-Smith V, Hoad C, Marciani L, Remes-Troche J, Gill S, Rossi M, Harris H, Ahn-Jarvis J, Warren F, Whelan K, Spiller R. Contrasting effects of viscous and particulate fibers on colonic fermentation in vitro and in vivo, and their impact on intestinal water studied by MRI in a randomized trial. Am J Clin Nutr. 2020 Sep 1;112(3):595-602. doi: 10.1093/ajcn/nqaa173.
Results Reference
derived
Learn more about this trial
A Study of the Effect of Bran, Psyllium and Nopal on Intestinal Water Content Using Magnetic Resonance Imaging
We'll reach out to this number within 24 hrs